AbbVie Inc. (ABBV) Announces Reimbursement for VRAYLAR® (cariprazine) for the Treatment of Schizophrenia

AbbVie Announces Reimbursement for VRAYLAR® (cariprazine) for the Treatment of Schizophrenia under…

Aurora Cannabis Inc. (ACB) to Host Third Quarter and Fiscal Year 2023 Investor Conference Call

Aurora Cannabis to Host Third Quarter and Fiscal Year 2023 Investor Conference…

AbbVie Inc. (ABBV) to Present at the Goldman Sachs 44th Annual Global Healthcare Conference

AbbVie to Present at the Goldman Sachs 44th Annual Global Healthcare Conference…